UCB Personalized Support Program
UCB
UnknownUnder review·Mar 14, 2026
UCB will provide a personalized support program for KYGEVVI that places the needs of patients and caregivers at the forefront. This program is for adults and pediatric patients living with thymidine kinase 2 deficiency (TK2d) with an age of symptom onset on or before 12 years.
Apply
Application goes directly to UCB. RxCopays does not receive compensation.
Go to application →